Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1Other 1

Conditions

Prostatic Neoplasms 9Breast Neoplasms 7Neoplasms 5Colorectal Neoplasms 5Lung Neoplasms 4Triple Negative Breast Neoplasms 2Sarcoma 2Pancreatic Neoplasms 2Hematopoietic and Lymphatic System Neoplasm 2Hematologic Neoplasms 2Depression 2Carcinoma, Non-Small-Cell Lung 2Anxiety Disorders 2Alzheimer Disease 2Advanced Malignant Solid Neoplasm 2Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Tobacco Smoking 1Testicular Neoplasms 1Spondylitis, Ankylosing 1Specific Learning Disorder 1Smoking Cessation 1Smoking 1Signs and Symptoms 1Sedentary Behavior 1Rectal Neoplasms 1Psoriasis 1Pancreatic Diseases 1Pancreatic Cyst 1Pain 1

Interventions

Standard of Care 1Spinal Cord Stimulation 1Specimen Handling 1Practice Guidelines as Topic 1Methods 1Massage 1Interviews as Topic 1Educational Status 1Early Intervention, Educational 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Chemotherapy-Induced Peripheral Neuropathy × Methods × Clear all
NCT07365007 2026-03-03

A Virtually Delivered Diet Intervention (LASO-3) for the Improvement of Chemotherapy-Induced Peripheral Neuropathy in Cancer Survivors Post-treatment

University of Michigan Rogel Cancer Center

Phase NA Recruiting
50 enrolled
OtherOther solid neoplasm

Chemotherapy-Induced Peripheral Neuropathy

Data powered by HemOnc (CC BY 4.0) Colophon âš¡